OXFORD & SHANGHAI–(BUSINESS WIRE)–Exscientia, an AI-driven pharmatech company with a mission to revolutionise how drugs are discovered, and GT Apeiron Therapeutics （Apeiron）, a Shanghai based company focused on novel oncology…
CAMBRIDGE, Mass. & OXFORD, England–(BUSINESS WIRE)–EQRx, a company committed to developing and delivering important new medicines to patients at radically lower prices, and Exscientia, an AI-driven pharmatech company with a…
CAMBRIDGE, Mass. & OXFORD, U.K.–(BUSINESS WIRE)–EQRx, a company committed to developing and delivering important new medicines to patients at radically lower prices, and Exscientia, an AI-driven pharmatech company with a…
OXFORD, Großbritannien–(BUSINESS WIRE)–Exscientia, ein Pharmatechnologieunternehmen der klinischen Phase, hat eine verbindliche Vereinbarung zur Übernahme von Allcyte unterzeichnet, einem führenden Unternehmen im Bereich der auf künstlicher Intelligenz (KI) basierenden Präzisionsmedizin. Die…
OXFORD, England–(BUSINESS WIRE)–Exscientia Ltd. (Headquarters: Oxford, UK; CEO: Andrew Hopkins) is pleased to acknowledge that Sumitomo Dainippon Pharma Co., Ltd. (Head office: Osaka, Japan, Representative Director, President and CEO: Hiroshi…